BioCentury
ARTICLE | Company News

Adamis, 3M deal

January 13, 2014 8:00 AM UTC

Adamis said it made a $7 million final payment and completed its acquisition of exclusive, worldwide rights to use 3M's Taper Dry Powder Inhaler (DPI) technology in all indications in the dry powder i...